SCHEMBL6155864

SCHEMBL6155864

COC(=O)CC(CC(=O)OC)C(=O)OCc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.43
FFAR1 O14842 1/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153075 0.86 KMT2A (0.44) KMT2ALMNAALDH1A1MAPTNPC1
SCHEMBL6156785 0.84 ALDH1A1 (0.52) KMT2AALDH1A1MAPTHTTNPC1
SCHEMBL6153847 0.84 GAA (0.46) KMT2AALDH1A1MAPTHTTRAB9A
SCHEMBL6156492 0.84 KMT2A (0.48) KMT2AKDM4EALDH1A1MAPTMEN1
SCHEMBL6155887 0.82 KDM4E (0.53) KDM4EMAPTRAB9AGAAMAOB
SCHEMBL6153746 0.80 GAA (0.52) ALDH1A1MAPTHTTRAB9AL3MBTL1
SCHEMBL16798223 0.78 CPA1 (0.47) KMT2AALDH1A1MAPTHTTCYP1A2
SCHEMBL27708800 0.78 TSHR (0.52) KMT2AKDM4ELMNAHTTNPC1
SCHEMBL9574213 0.77 ABCB1 (0.57) ALDH1A1L3MBTL1MAOBCYP1A2CYP2C19
SCHEMBL23185452 0.76 KMT2A (0.48) KMT2AKDM4ELMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-06-02 US disclosed
EP-1500642-A1 3-SUBSTITUTED OXYGLUTARIC DIESTER COMPOUND, OPTICALLY ACTIVE 3-SUBSTITUTED OXYGLUTARIC MONOESTER COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119341-A1 3-substituted oxyglutaric diester compound, optically active 3-substituted oxyglutaric monoester compound, and processes for producing these OGDH, GLUL, ADSL KMT2A 2290/4885KDM4E 717/4885LMNA 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.